Drugs / Cidapenem
last change Dec 2024 re-read 2 minutes ago

Cidapenem

Developed for
Nodal T-follicular helper cell lymphoma, follicular type
Investigated by
The First Affiliated Hospital with Nanjing Medical University

Trials 1 · a red edge is where a trial was stopped

PhaseRegistry idDatesIndicationSponsorStatusOutcome
NCT05772728 Apr → Dec 2023 Nodal T-follicular helper cell lymphoma, follicular type The First Affiliated Hospital with Nanjing Medical University Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Cidapenem ClinicalTrials.gov intervention name — accepted as the source's own label NCT05772728